BACKGROUND: Application of @entity1702 ( @entity1702 ) to treat @entity1 suffering from @entity5 (GDOO) is today considered a well-recognized palliative treatment. Use of @entity1702 has emerged as an attractive alternative to surgical treatment of such @entity1 . PURPOSE: To report the immediate and the mid-term clinical outcomes from a series of consecutive @entity1 treated with exclusively fluoroscopic-guided insertion of @entity1702 . MATERIAL AND METHODS: This was a retrospective study including @entity1 suffering from GDOO that were either ineligible for or unwilling to undergo surgery. @entity1 with potentially curable disease, uncorrectable @entity1003 , @entity344 , @entity295 , presence of @entity1744 , and @entity63 were excluded. Technical success, clinical success, and major complications were calculated. In addition, stent migration, stent re-obstruction, restenosis, and overall re-interventions due to recurrent symptoms were considered. Kaplan-Meier survival analysis was used for @entity1 survival estimation while both bivariable and multivariable analysis were performed to identify any independent predictors of outcomes. RESULTS: Fifty-one @entity1 , (mean age, 63.73        15.62 years) met the study's criteria and were included in the final analysis. Technical and clinical success were 90.19% (n   =   46/51) and 91.30% (n   =   42/46), respectively. Major complications rate was 3.92%. Stent migration was noted in four cases. @entity256 and re-obstruction rates were 19.57% and 10.87%, respectively. No cases of peri-procedural mortality were noted, while Kaplan-Meier estimates for 1- and 2-year survival were 16.8% and 7.2%, respectively. Clinically successful cases and @entity1 with primary @entity5 were related with more favorable survival compared to unsuccessful and @entity1 suffering from GDOO due to extrinsic compression by neoplastic or @entity1600 . CONCLUSION: Exclusively fluoroscopically inserted @entity1702 for GDOO is safe and highly effective method for palliative treatment.

Fluoroscopic-guided insertion of XXXX for @entity5 : immediate results and clinical outcomes.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity295 :: ('MESH:D018805', 'Disease') :: ['sepsis'] @entity63 :: ('MESH:D007511', 'Disease') :: ['bowel ischemia'] @entity5 :: ('MESH:D009369', 'Disease') :: ['GI tumor', 'malignant gastroduodenal outlet obstruction'] @entity1600 :: ('MESH:D014388', 'Disease') :: ['lymph node disease'] @entity344 :: ('MESH:D005767', 'Disease') :: ['gastrointestinal perforation'] @entity1003 :: ('MESH:D001778', 'Disease') :: ['coagulopathy'] @entity1702 :: ('MESH:D013651', 'Disease') :: ['self-expanding metal stents', 'SEMS'] @entity256 :: ('MESH:D023903', 'Disease') :: ['Restenosis'] @entity1744 :: ('MESH:D043183', 'Disease') :: ['distal small bowel obstruction']
@entity1702 :: (MESH:D013651,Disease) :: ['self-expanding metal stents']
